Previously, the EpCAM-targeting toxin fusion protein Ec1–LoPE (43 kDa) was studied in prostate cancer cells, ovarian cancer cells, and breast cancer cells for its cytotoxic effect [47,48,49]. Here, EPCAM is linked to ovarian carcinoma.